Eric Oligino

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy”.

Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy

Cardio-Oncology(2023)10.1186/s40959-023-00163-4

N/A

0.496DataRank · unranked

5 citations

Chau T. Dang, Justine Jorgensen, Chaya S. Moskowitz, Patricia DeFusco, Eric Oligino +4 more

COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease

Translational Oncology(2023)10.1016/j.tranon.2023.101709

N/A

0.115DataRank · unranked

1 citations

Cassandra Hennessy, Benjamin French, Jeremy L. Warner, Matthew D. Tucker, Daniel Hausrath +62 more

Cardiac safety of reduced surveillance for cancer therapy related cardiac dysfunction in patients with breast cancer treated with HER2-targeted therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12083

N/A

0DataRank · unranked

1 citations

Chau T. Dang, Justine Jorgensen, Chaya S. Moskowitz, Joseph Wallins, Patricia DeFusco +5 more

Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy

JACC CardioOncology(2025)10.1016/j.jaccao.2025.05.006

N/A

0DataRank · unranked

8 citations

Chau T. Dang, Chaya S. Moskowitz, Akriti Mishra Meza, Patricia DeFusco, Eric Oligino +11 more